Randomization to the high Hb target group had a no effect on the primary composite cardiovascular end point, but a higher risk of venous and arterial thromboembolic events and stroke was observed, the latter unrelated to mean arterial blood pressure. This evidence concerns the gene GSTM1 and Stroke.